Blood level monitoring helps to determine the therapeutic and toxic ra
nges for anticonvulsants and antidepressants. We investigated initial
drug-drug interactions between lamotrigine and sertraline. We report o
n case histories of two epileptic patients who were initially on lamot
rigine and to whom sertraline was added to control psychiatric feature
s. In case 1, a total daily dose of 25 mg sertraline, with nondetectab
le sertraline and desmethylsertraline blood levels, resulted in a doub
ling of the lamotrigine blood level with symptoms of toxicity. In case
2, a 25 mg reduction in the total daily dose of sertraline resulted i
n halving of the lamotrigine blood level even though the lamotrigine d
osage was increased by 33%. This shows that sertraline has potent inte
ractions with lamotrigine metabolism. The authors hypothesize that inh
ibition of glucuronidation is responsible. Clinicians are advised to o
bserve for symptoms of toxicity and to do serial blood levels to monit
or this interaction.